KDIGO Opens 2026 Draft Guideline for Public Review: Learn more
✕
The following sell-side analyst covers BioPorto:
Oliver Røst BenneballeEquity analyst
Direct: +45 2555 0117[email protected]
Yi ChenTel: + 1 (212) 916-3971